nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpromazine—ABCB11—Progesterone—uterine cancer	0.182	0.305	CbGbCtD
Chlorpromazine—SLC22A1—Progesterone—uterine cancer	0.102	0.17	CbGbCtD
Chlorpromazine—ABCB11—Doxorubicin—uterine cancer	0.0557	0.093	CbGbCtD
Chlorpromazine—CYP1A2—Progesterone—uterine cancer	0.0357	0.0597	CbGbCtD
Chlorpromazine—ABCB1—Progesterone—uterine cancer	0.0313	0.0522	CbGbCtD
Chlorpromazine—CYP2D6—Progesterone—uterine cancer	0.0295	0.0492	CbGbCtD
Chlorpromazine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0283	0.0472	CbGbCtD
Chlorpromazine—CYP2E1—Etoposide—uterine cancer	0.0277	0.0462	CbGbCtD
Chlorpromazine—ABCB1—Dactinomycin—uterine cancer	0.0248	0.0414	CbGbCtD
Chlorpromazine—CYP3A4—Progesterone—uterine cancer	0.0187	0.0313	CbGbCtD
Chlorpromazine—CYP1A2—Etoposide—uterine cancer	0.016	0.0267	CbGbCtD
Chlorpromazine—ABCB1—Etoposide—uterine cancer	0.014	0.0234	CbGbCtD
Chlorpromazine—CHRM3—ureter—uterine cancer	0.00976	0.0741	CbGeAlD
Chlorpromazine—ABCB1—Doxorubicin—uterine cancer	0.00954	0.0159	CbGbCtD
Chlorpromazine—CYP2D6—Doxorubicin—uterine cancer	0.00899	0.015	CbGbCtD
Chlorpromazine—CYP3A4—Etoposide—uterine cancer	0.00838	0.014	CbGbCtD
Chlorpromazine—CHRM3—muscle of abdomen—uterine cancer	0.00702	0.0533	CbGeAlD
Chlorpromazine—CYP3A4—Doxorubicin—uterine cancer	0.00572	0.00955	CbGbCtD
Chlorpromazine—Hyperpyrexia—Medroxyprogesterone Acetate—uterine cancer	0.00454	0.0327	CcSEcCtD
Chlorpromazine—CALM2—semen—uterine cancer	0.00444	0.0337	CbGeAlD
Chlorpromazine—CALM1—semen—uterine cancer	0.00442	0.0336	CbGeAlD
Chlorpromazine—Throat tightness—Progesterone—uterine cancer	0.0038	0.0274	CcSEcCtD
Chlorpromazine—Parkinsonism—Medroxyprogesterone Acetate—uterine cancer	0.00372	0.0268	CcSEcCtD
Chlorpromazine—CALM2—oviduct—uterine cancer	0.00326	0.0247	CbGeAlD
Chlorpromazine—Pigmentation disorder—Etoposide—uterine cancer	0.00286	0.0206	CcSEcCtD
Chlorpromazine—Laryngeal oedema—Medroxyprogesterone Acetate—uterine cancer	0.00263	0.019	CcSEcCtD
Chlorpromazine—Menorrhagia—Progesterone—uterine cancer	0.00252	0.0181	CcSEcCtD
Chlorpromazine—Menorrhagia—Medroxyprogesterone Acetate—uterine cancer	0.00228	0.0164	CcSEcCtD
Chlorpromazine—Endocrine disorder—Progesterone—uterine cancer	0.00225	0.0162	CcSEcCtD
Chlorpromazine—CALM2—artery—uterine cancer	0.00216	0.0164	CbGeAlD
Chlorpromazine—CALM1—artery—uterine cancer	0.00215	0.0163	CbGeAlD
Chlorpromazine—SMPD1—decidua—uterine cancer	0.00212	0.0161	CbGeAlD
Chlorpromazine—Jaundice cholestatic—Progesterone—uterine cancer	0.00212	0.0153	CcSEcCtD
Chlorpromazine—Amenorrhoea—Progesterone—uterine cancer	0.00212	0.0153	CcSEcCtD
Chlorpromazine—HTR7—artery—uterine cancer	0.0021	0.0159	CbGeAlD
Chlorpromazine—Glycosuria—Medroxyprogesterone Acetate—uterine cancer	0.00209	0.015	CcSEcCtD
Chlorpromazine—SMPD1—renal system—uterine cancer	0.00208	0.0158	CbGeAlD
Chlorpromazine—Endocrine disorder—Medroxyprogesterone Acetate—uterine cancer	0.00204	0.0147	CcSEcCtD
Chlorpromazine—Blood disorder—Medroxyprogesterone Acetate—uterine cancer	0.00202	0.0146	CcSEcCtD
Chlorpromazine—Throat tightness—Etoposide—uterine cancer	0.00195	0.014	CcSEcCtD
Chlorpromazine—Jaundice cholestatic—Medroxyprogesterone Acetate—uterine cancer	0.00192	0.0138	CcSEcCtD
Chlorpromazine—Amenorrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00192	0.0138	CcSEcCtD
Chlorpromazine—CHRM3—exocrine gland—uterine cancer	0.00192	0.0146	CbGeAlD
Chlorpromazine—Gait disturbance—Progesterone—uterine cancer	0.00191	0.0138	CcSEcCtD
Chlorpromazine—CALM2—exocrine gland—uterine cancer	0.00188	0.0143	CbGeAlD
Chlorpromazine—CALM1—exocrine gland—uterine cancer	0.00187	0.0142	CbGeAlD
Chlorpromazine—SMPD1—female reproductive system—uterine cancer	0.00167	0.0127	CbGeAlD
Chlorpromazine—Pigmentation disorder—Epirubicin—uterine cancer	0.0016	0.0115	CcSEcCtD
Chlorpromazine—SMPD1—female gonad—uterine cancer	0.00152	0.0115	CbGeAlD
Chlorpromazine—SMPD1—vagina—uterine cancer	0.00151	0.0115	CbGeAlD
Chlorpromazine—Nasal congestion—Progesterone—uterine cancer	0.00149	0.0107	CcSEcCtD
Chlorpromazine—Pigmentation disorder—Doxorubicin—uterine cancer	0.00148	0.0107	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Progesterone—uterine cancer	0.0014	0.0101	CcSEcCtD
Chlorpromazine—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00978	CcSEcCtD
Chlorpromazine—CALM3—myometrium—uterine cancer	0.00133	0.0101	CbGeAlD
Chlorpromazine—HTR2A—artery—uterine cancer	0.00131	0.00994	CbGeAlD
Chlorpromazine—ADRA1B—renal system—uterine cancer	0.00127	0.00962	CbGeAlD
Chlorpromazine—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00913	CcSEcCtD
Chlorpromazine—Infection—Carboplatin—uterine cancer	0.00126	0.00906	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00905	CcSEcCtD
Chlorpromazine—DRD5—female reproductive system—uterine cancer	0.00124	0.0094	CbGeAlD
Chlorpromazine—Aplastic anaemia—Dactinomycin—uterine cancer	0.00124	0.00891	CcSEcCtD
Chlorpromazine—HTR2B—myometrium—uterine cancer	0.00118	0.00899	CbGeAlD
Chlorpromazine—Asthma—Progesterone—uterine cancer	0.00117	0.00842	CcSEcCtD
Chlorpromazine—Dysphagia—Progesterone—uterine cancer	0.00117	0.00842	CcSEcCtD
Chlorpromazine—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.0084	CcSEcCtD
Chlorpromazine—DRD5—female gonad—uterine cancer	0.00113	0.00856	CbGeAlD
Chlorpromazine—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00807	CcSEcCtD
Chlorpromazine—Asthma—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00763	CcSEcCtD
Chlorpromazine—Dysphagia—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00763	CcSEcCtD
Chlorpromazine—Influenza—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00763	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Progesterone—uterine cancer	0.00106	0.0076	CcSEcCtD
Chlorpromazine—Drowsiness—Progesterone—uterine cancer	0.00104	0.00751	CcSEcCtD
Chlorpromazine—CALM2—myometrium—uterine cancer	0.00104	0.00792	CbGeAlD
Chlorpromazine—CALM1—myometrium—uterine cancer	0.00104	0.00788	CbGeAlD
Chlorpromazine—CALM3—uterine cervix—uterine cancer	0.00103	0.00785	CbGeAlD
Chlorpromazine—Jaundice—Progesterone—uterine cancer	0.00102	0.00732	CcSEcCtD
Chlorpromazine—CALM3—smooth muscle tissue—uterine cancer	0.001	0.00763	CbGeAlD
Chlorpromazine—Body temperature increased—Carboplatin—uterine cancer	0.001	0.00721	CcSEcCtD
Chlorpromazine—CALM3—decidua—uterine cancer	0.000985	0.00748	CbGeAlD
Chlorpromazine—SMPD1—lymph node—uterine cancer	0.000977	0.00742	CbGeAlD
Chlorpromazine—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.000956	0.00689	CcSEcCtD
Chlorpromazine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.000945	0.00681	CcSEcCtD
Chlorpromazine—KCNH2—myometrium—uterine cancer	0.000945	0.00717	CbGeAlD
Chlorpromazine—SLC22A1—renal system—uterine cancer	0.000935	0.0071	CbGeAlD
Chlorpromazine—CALM3—endometrium—uterine cancer	0.000935	0.0071	CbGeAlD
Chlorpromazine—Oedema peripheral—Progesterone—uterine cancer	0.000923	0.00664	CcSEcCtD
Chlorpromazine—HTR2B—uterine cervix—uterine cancer	0.000922	0.007	CbGeAlD
Chlorpromazine—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.000922	0.00663	CcSEcCtD
Chlorpromazine—CALM3—mammalian vulva—uterine cancer	0.000904	0.00686	CbGeAlD
Chlorpromazine—Visual impairment—Progesterone—uterine cancer	0.000903	0.0065	CcSEcCtD
Chlorpromazine—HTR2B—smooth muscle tissue—uterine cancer	0.000896	0.0068	CbGeAlD
Chlorpromazine—HTR2B—decidua—uterine cancer	0.000878	0.00667	CbGeAlD
Chlorpromazine—BCHE—myometrium—uterine cancer	0.00087	0.0066	CbGeAlD
Chlorpromazine—CALM3—uterus—uterine cancer	0.000861	0.00654	CbGeAlD
Chlorpromazine—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.000836	0.00602	CcSEcCtD
Chlorpromazine—HTR2B—endometrium—uterine cancer	0.000834	0.00633	CbGeAlD
Chlorpromazine—Dysphagia—Dactinomycin—uterine cancer	0.000827	0.00595	CcSEcCtD
Chlorpromazine—CALM2—epithelium—uterine cancer	0.000819	0.00621	CbGeAlD
Chlorpromazine—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.000818	0.00589	CcSEcCtD
Chlorpromazine—CALM1—epithelium—uterine cancer	0.000815	0.00619	CbGeAlD
Chlorpromazine—CALM2—uterine cervix—uterine cancer	0.000812	0.00616	CbGeAlD
Chlorpromazine—CALM1—uterine cervix—uterine cancer	0.000808	0.00613	CbGeAlD
Chlorpromazine—CHRM3—smooth muscle tissue—uterine cancer	0.000806	0.00612	CbGeAlD
Chlorpromazine—HTR7—epithelium—uterine cancer	0.000796	0.00604	CbGeAlD
Chlorpromazine—Nervousness—Progesterone—uterine cancer	0.000792	0.0057	CcSEcCtD
Chlorpromazine—CALM2—smooth muscle tissue—uterine cancer	0.000789	0.00599	CbGeAlD
Chlorpromazine—Pancytopenia—Dactinomycin—uterine cancer	0.000785	0.00565	CcSEcCtD
Chlorpromazine—CALM1—smooth muscle tissue—uterine cancer	0.000785	0.00596	CbGeAlD
Chlorpromazine—Muscle spasms—Progesterone—uterine cancer	0.000784	0.00564	CcSEcCtD
Chlorpromazine—CHRM3—renal system—uterine cancer	0.000776	0.00589	CbGeAlD
Chlorpromazine—CALM2—decidua—uterine cancer	0.000773	0.00587	CbGeAlD
Chlorpromazine—HTR1A—renal system—uterine cancer	0.000773	0.00587	CbGeAlD
Chlorpromazine—CALM1—decidua—uterine cancer	0.00077	0.00584	CbGeAlD
Chlorpromazine—HTR2B—uterus—uterine cancer	0.000768	0.00583	CbGeAlD
Chlorpromazine—ADRA1A—epithelium—uterine cancer	0.000768	0.00583	CbGeAlD
Chlorpromazine—HTR7—smooth muscle tissue—uterine cancer	0.000767	0.00582	CbGeAlD
Chlorpromazine—Tremor—Progesterone—uterine cancer	0.000764	0.0055	CcSEcCtD
Chlorpromazine—CALM2—renal system—uterine cancer	0.000759	0.00576	CbGeAlD
Chlorpromazine—HRH1—myometrium—uterine cancer	0.000757	0.00575	CbGeAlD
Chlorpromazine—CALM1—renal system—uterine cancer	0.000756	0.00574	CbGeAlD
Chlorpromazine—Angioedema—Progesterone—uterine cancer	0.000745	0.00536	CcSEcCtD
Chlorpromazine—ADRA2A—myometrium—uterine cancer	0.000744	0.00565	CbGeAlD
Chlorpromazine—HTR7—renal system—uterine cancer	0.000738	0.00561	CbGeAlD
Chlorpromazine—KCNH2—uterine cervix—uterine cancer	0.000735	0.00558	CbGeAlD
Chlorpromazine—HTR2C—female reproductive system—uterine cancer	0.000735	0.00558	CbGeAlD
Chlorpromazine—CALM2—endometrium—uterine cancer	0.000734	0.00557	CbGeAlD
Chlorpromazine—Syncope—Progesterone—uterine cancer	0.000731	0.00526	CcSEcCtD
Chlorpromazine—CALM1—endometrium—uterine cancer	0.000731	0.00555	CbGeAlD
Chlorpromazine—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.000718	0.00517	CcSEcCtD
Chlorpromazine—Loss of consciousness—Progesterone—uterine cancer	0.000717	0.00516	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Etoposide—uterine cancer	0.000716	0.00515	CcSEcCtD
Chlorpromazine—ADRA1A—renal system—uterine cancer	0.000712	0.00541	CbGeAlD
Chlorpromazine—Cough—Progesterone—uterine cancer	0.000711	0.00512	CcSEcCtD
Chlorpromazine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00071	0.00511	CcSEcCtD
Chlorpromazine—CALM2—mammalian vulva—uterine cancer	0.00071	0.00539	CbGeAlD
Chlorpromazine—CALM1—mammalian vulva—uterine cancer	0.000707	0.00537	CbGeAlD
Chlorpromazine—Convulsion—Progesterone—uterine cancer	0.000706	0.00509	CcSEcCtD
Chlorpromazine—CALM3—female gonad—uterine cancer	0.000705	0.00535	CbGeAlD
Chlorpromazine—CALM3—vagina—uterine cancer	0.0007	0.00532	CbGeAlD
Chlorpromazine—CHRM1—female reproductive system—uterine cancer	0.000694	0.00527	CbGeAlD
Chlorpromazine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.000692	0.00498	CcSEcCtD
Chlorpromazine—HTR2B—female reproductive system—uterine cancer	0.000691	0.00524	CbGeAlD
Chlorpromazine—Agranulocytosis—Dactinomycin—uterine cancer	0.000688	0.00495	CcSEcCtD
Chlorpromazine—KCNH2—renal system—uterine cancer	0.000688	0.00522	CbGeAlD
Chlorpromazine—Dry mouth—Progesterone—uterine cancer	0.000679	0.00489	CcSEcCtD
Chlorpromazine—SLC22A1—vagina—uterine cancer	0.000677	0.00514	CbGeAlD
Chlorpromazine—BCHE—uterine cervix—uterine cancer	0.000677	0.00514	CbGeAlD
Chlorpromazine—CALM2—uterus—uterine cancer	0.000676	0.00514	CbGeAlD
Chlorpromazine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.000675	0.00486	CcSEcCtD
Chlorpromazine—CALM1—uterus—uterine cancer	0.000673	0.00511	CbGeAlD
Chlorpromazine—Anaphylactic shock—Progesterone—uterine cancer	0.000665	0.00479	CcSEcCtD
Chlorpromazine—KCNH2—endometrium—uterine cancer	0.000665	0.00505	CbGeAlD
Chlorpromazine—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.000663	0.00477	CcSEcCtD
Chlorpromazine—Infection—Progesterone—uterine cancer	0.000661	0.00476	CcSEcCtD
Chlorpromazine—Glycosuria—Epirubicin—uterine cancer	0.00066	0.00475	CcSEcCtD
Chlorpromazine—Cardiac arrest—Etoposide—uterine cancer	0.000659	0.00474	CcSEcCtD
Chlorpromazine—BCHE—smooth muscle tissue—uterine cancer	0.000658	0.00499	CbGeAlD
Chlorpromazine—Shock—Progesterone—uterine cancer	0.000655	0.00471	CcSEcCtD
Chlorpromazine—Tachycardia—Progesterone—uterine cancer	0.000649	0.00468	CcSEcCtD
Chlorpromazine—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.000649	0.00467	CcSEcCtD
Chlorpromazine—Blood disorder—Epirubicin—uterine cancer	0.00064	0.00461	CcSEcCtD
Chlorpromazine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00064	0.00461	CcSEcCtD
Chlorpromazine—HTR2B—vagina—uterine cancer	0.000624	0.00474	CbGeAlD
Chlorpromazine—Hypotension—Progesterone—uterine cancer	0.000622	0.00448	CcSEcCtD
Chlorpromazine—CHRM3—female reproductive system—uterine cancer	0.000621	0.00472	CbGeAlD
Chlorpromazine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000615	0.00443	CcSEcCtD
Chlorpromazine—KCNH2—uterus—uterine cancer	0.000613	0.00465	CbGeAlD
Chlorpromazine—BCHE—endometrium—uterine cancer	0.000612	0.00465	CbGeAlD
Chlorpromazine—Glycosuria—Doxorubicin—uterine cancer	0.000611	0.0044	CcSEcCtD
Chlorpromazine—Amenorrhoea—Epirubicin—uterine cancer	0.000609	0.00438	CcSEcCtD
Chlorpromazine—Jaundice cholestatic—Epirubicin—uterine cancer	0.000609	0.00438	CcSEcCtD
Chlorpromazine—CALM2—female reproductive system—uterine cancer	0.000608	0.00462	CbGeAlD
Chlorpromazine—CALM1—female reproductive system—uterine cancer	0.000605	0.0046	CbGeAlD
Chlorpromazine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000603	0.00434	CcSEcCtD
Chlorpromazine—Insomnia—Progesterone—uterine cancer	0.000602	0.00433	CcSEcCtD
Chlorpromazine—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000599	0.00431	CcSEcCtD
Chlorpromazine—Dysphagia—Etoposide—uterine cancer	0.000599	0.00431	CcSEcCtD
Chlorpromazine—HRH1—epithelium—uterine cancer	0.000594	0.00451	CbGeAlD
Chlorpromazine—Dyspnoea—Progesterone—uterine cancer	0.000593	0.00427	CcSEcCtD
Chlorpromazine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000593	0.00427	CcSEcCtD
Chlorpromazine—Blood disorder—Doxorubicin—uterine cancer	0.000592	0.00427	CcSEcCtD
Chlorpromazine—BCHE—mammalian vulva—uterine cancer	0.000592	0.0045	CbGeAlD
Chlorpromazine—Somnolence—Progesterone—uterine cancer	0.000592	0.00426	CcSEcCtD
Chlorpromazine—HTR7—female reproductive system—uterine cancer	0.000591	0.00449	CbGeAlD
Chlorpromazine—HRH1—uterine cervix—uterine cancer	0.000589	0.00447	CbGeAlD
Chlorpromazine—CYP1A2—renal system—uterine cancer	0.000589	0.00447	CbGeAlD
Chlorpromazine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000588	0.00424	CcSEcCtD
Chlorpromazine—ADRA2A—uterine cervix—uterine cancer	0.000579	0.00439	CbGeAlD
Chlorpromazine—HRH1—smooth muscle tissue—uterine cancer	0.000573	0.00435	CbGeAlD
Chlorpromazine—Dyskinesia—Epirubicin—uterine cancer	0.000569	0.0041	CcSEcCtD
Chlorpromazine—Constipation—Progesterone—uterine cancer	0.000569	0.0041	CcSEcCtD
Chlorpromazine—Pancytopenia—Etoposide—uterine cancer	0.000568	0.00409	CcSEcCtD
Chlorpromazine—CHRM3—female gonad—uterine cancer	0.000565	0.00429	CbGeAlD
Chlorpromazine—BCHE—uterus—uterine cancer	0.000564	0.00428	CbGeAlD
Chlorpromazine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000563	0.00406	CcSEcCtD
Chlorpromazine—Amenorrhoea—Doxorubicin—uterine cancer	0.000563	0.00405	CcSEcCtD
Chlorpromazine—Jaundice cholestatic—Doxorubicin—uterine cancer	0.000563	0.00405	CcSEcCtD
Chlorpromazine—HRH1—decidua—uterine cancer	0.000561	0.00426	CbGeAlD
Chlorpromazine—CALM2—female gonad—uterine cancer	0.000553	0.0042	CbGeAlD
Chlorpromazine—ADRA2A—decidua—uterine cancer	0.000551	0.00419	CbGeAlD
Chlorpromazine—KCNH2—female reproductive system—uterine cancer	0.000551	0.00418	CbGeAlD
Chlorpromazine—CALM1—female gonad—uterine cancer	0.000551	0.00418	CbGeAlD
Chlorpromazine—CALM2—vagina—uterine cancer	0.00055	0.00418	CbGeAlD
Chlorpromazine—Gait disturbance—Epirubicin—uterine cancer	0.000548	0.00395	CcSEcCtD
Chlorpromazine—CALM1—vagina—uterine cancer	0.000547	0.00416	CbGeAlD
Chlorpromazine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000545	0.00393	CcSEcCtD
Chlorpromazine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000538	0.00387	CcSEcCtD
Chlorpromazine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000536	0.00386	CcSEcCtD
Chlorpromazine—HRH1—endometrium—uterine cancer	0.000533	0.00405	CbGeAlD
Chlorpromazine—CYP2E1—renal system—uterine cancer	0.00053	0.00402	CbGeAlD
Chlorpromazine—Dermatitis contact—Epirubicin—uterine cancer	0.000529	0.00381	CcSEcCtD
Chlorpromazine—Dyskinesia—Doxorubicin—uterine cancer	0.000527	0.00379	CcSEcCtD
Chlorpromazine—Body temperature increased—Progesterone—uterine cancer	0.000526	0.00379	CcSEcCtD
Chlorpromazine—ADRA2A—endometrium—uterine cancer	0.000523	0.00397	CbGeAlD
Chlorpromazine—Jaundice—Etoposide—uterine cancer	0.00052	0.00375	CcSEcCtD
Chlorpromazine—Leukopenia—Dactinomycin—uterine cancer	0.000516	0.00371	CcSEcCtD
Chlorpromazine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000516	0.00371	CcSEcCtD
Chlorpromazine—HRH1—mammalian vulva—uterine cancer	0.000516	0.00391	CbGeAlD
Chlorpromazine—Gait disturbance—Doxorubicin—uterine cancer	0.000507	0.00365	CcSEcCtD
Chlorpromazine—BCHE—female reproductive system—uterine cancer	0.000507	0.00385	CbGeAlD
Chlorpromazine—ADRA2A—mammalian vulva—uterine cancer	0.000506	0.00384	CbGeAlD
Chlorpromazine—Aplastic anaemia—Epirubicin—uterine cancer	0.000502	0.00362	CcSEcCtD
Chlorpromazine—KCNH2—female gonad—uterine cancer	0.000501	0.00381	CbGeAlD
Chlorpromazine—KCNH2—vagina—uterine cancer	0.000498	0.00378	CbGeAlD
Chlorpromazine—Agranulocytosis—Etoposide—uterine cancer	0.000498	0.00359	CcSEcCtD
Chlorpromazine—HTR2A—epithelium—uterine cancer	0.000496	0.00377	CbGeAlD
Chlorpromazine—Hypersensitivity—Progesterone—uterine cancer	0.00049	0.00353	CcSEcCtD
Chlorpromazine—Dermatitis contact—Doxorubicin—uterine cancer	0.000489	0.00352	CcSEcCtD
Chlorpromazine—ADRA2A—uterus—uterine cancer	0.000482	0.00366	CbGeAlD
Chlorpromazine—HTR2A—smooth muscle tissue—uterine cancer	0.000478	0.00363	CbGeAlD
Chlorpromazine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000477	0.00343	CcSEcCtD
Chlorpromazine—Infection—Dactinomycin—uterine cancer	0.000467	0.00336	CcSEcCtD
Chlorpromazine—Aplastic anaemia—Doxorubicin—uterine cancer	0.000465	0.00334	CcSEcCtD
Chlorpromazine—HTR2A—renal system—uterine cancer	0.00046	0.0035	CbGeAlD
Chlorpromazine—BCHE—vagina—uterine cancer	0.000459	0.00348	CbGeAlD
Chlorpromazine—CALM3—lymph node—uterine cancer	0.000453	0.00344	CbGeAlD
Chlorpromazine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000444	0.0032	CcSEcCtD
Chlorpromazine—Photosensitivity—Epirubicin—uterine cancer	0.000442	0.00318	CcSEcCtD
Chlorpromazine—HRH1—female reproductive system—uterine cancer	0.000441	0.00335	CbGeAlD
Chlorpromazine—Dizziness—Progesterone—uterine cancer	0.00044	0.00317	CcSEcCtD
Chlorpromazine—ADRA2A—female reproductive system—uterine cancer	0.000434	0.00329	CbGeAlD
Chlorpromazine—CYP3A4—renal system—uterine cancer	0.000426	0.00324	CbGeAlD
Chlorpromazine—CYP2E1—female reproductive system—uterine cancer	0.000424	0.00322	CbGeAlD
Chlorpromazine—ALB—lymph node—uterine cancer	0.00042	0.00319	CbGeAlD
Chlorpromazine—CYP2D6—renal system—uterine cancer	0.000419	0.00318	CbGeAlD
Chlorpromazine—ABCB1—myometrium—uterine cancer	0.000414	0.00315	CbGeAlD
Chlorpromazine—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000411	0.00296	CcSEcCtD
Chlorpromazine—Photosensitivity—Doxorubicin—uterine cancer	0.000409	0.00295	CcSEcCtD
Chlorpromazine—HTR2B—lymph node—uterine cancer	0.000404	0.00307	CbGeAlD
Chlorpromazine—HRH1—female gonad—uterine cancer	0.000402	0.00305	CbGeAlD
Chlorpromazine—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000401	0.00289	CcSEcCtD
Chlorpromazine—Muscle spasms—Etoposide—uterine cancer	0.000401	0.00289	CcSEcCtD
Chlorpromazine—HRH1—vagina—uterine cancer	0.000399	0.00303	CbGeAlD
Chlorpromazine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000399	0.00287	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Epirubicin—uterine cancer	0.000398	0.00286	CcSEcCtD
Chlorpromazine—ADRA2A—female gonad—uterine cancer	0.000395	0.003	CbGeAlD
Chlorpromazine—ADRA2A—vagina—uterine cancer	0.000392	0.00298	CbGeAlD
Chlorpromazine—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000381	0.00274	CcSEcCtD
Chlorpromazine—Leukopenia—Etoposide—uterine cancer	0.000373	0.00269	CcSEcCtD
Chlorpromazine—Body temperature increased—Dactinomycin—uterine cancer	0.000372	0.00268	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000371	0.00267	CcSEcCtD
Chlorpromazine—Cardiac arrest—Epirubicin—uterine cancer	0.000369	0.00266	CcSEcCtD
Chlorpromazine—HTR2A—female reproductive system—uterine cancer	0.000369	0.0028	CbGeAlD
Chlorpromazine—Hypoglycaemia—Doxorubicin—uterine cancer	0.000368	0.00265	CcSEcCtD
Chlorpromazine—Loss of consciousness—Etoposide—uterine cancer	0.000367	0.00264	CcSEcCtD
Chlorpromazine—Cough—Etoposide—uterine cancer	0.000364	0.00262	CcSEcCtD
Chlorpromazine—Convulsion—Etoposide—uterine cancer	0.000361	0.0026	CcSEcCtD
Chlorpromazine—CALM2—lymph node—uterine cancer	0.000356	0.0027	CbGeAlD
Chlorpromazine—Orthostatic hypotension—Epirubicin—uterine cancer	0.000355	0.00255	CcSEcCtD
Chlorpromazine—CALM1—lymph node—uterine cancer	0.000354	0.00269	CbGeAlD
Chlorpromazine—Hypersensitivity—Dactinomycin—uterine cancer	0.000347	0.00249	CcSEcCtD
Chlorpromazine—Cardiac arrest—Doxorubicin—uterine cancer	0.000342	0.00246	CcSEcCtD
Chlorpromazine—CYP3A4—female reproductive system—uterine cancer	0.000341	0.00259	CbGeAlD
Chlorpromazine—Anaphylactic shock—Etoposide—uterine cancer	0.00034	0.00245	CcSEcCtD
Chlorpromazine—Infection—Etoposide—uterine cancer	0.000338	0.00243	CcSEcCtD
Chlorpromazine—CYP2D6—female reproductive system—uterine cancer	0.000336	0.00255	CbGeAlD
Chlorpromazine—Dysphagia—Epirubicin—uterine cancer	0.000336	0.00242	CcSEcCtD
Chlorpromazine—Influenza—Epirubicin—uterine cancer	0.000336	0.00242	CcSEcCtD
Chlorpromazine—Asthma—Epirubicin—uterine cancer	0.000336	0.00242	CcSEcCtD
Chlorpromazine—HTR2A—vagina—uterine cancer	0.000333	0.00253	CbGeAlD
Chlorpromazine—Tachycardia—Etoposide—uterine cancer	0.000332	0.00239	CcSEcCtD
Chlorpromazine—Eosinophilia—Epirubicin—uterine cancer	0.000332	0.00239	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000328	0.00236	CcSEcCtD
Chlorpromazine—ABCB1—epithelium—uterine cancer	0.000325	0.00247	CbGeAlD
Chlorpromazine—ABCB1—uterine cervix—uterine cancer	0.000323	0.00245	CbGeAlD
Chlorpromazine—KCNH2—lymph node—uterine cancer	0.000322	0.00245	CbGeAlD
Chlorpromazine—Pancytopenia—Epirubicin—uterine cancer	0.000319	0.00229	CcSEcCtD
Chlorpromazine—Hypotension—Etoposide—uterine cancer	0.000318	0.00229	CcSEcCtD
Chlorpromazine—Asthma—Doxorubicin—uterine cancer	0.00031	0.00224	CcSEcCtD
Chlorpromazine—Dysphagia—Doxorubicin—uterine cancer	0.00031	0.00224	CcSEcCtD
Chlorpromazine—Influenza—Doxorubicin—uterine cancer	0.00031	0.00224	CcSEcCtD
Chlorpromazine—Eosinophilia—Doxorubicin—uterine cancer	0.000307	0.00221	CcSEcCtD
Chlorpromazine—ABCB1—decidua—uterine cancer	0.000307	0.00233	CbGeAlD
Chlorpromazine—Photosensitivity reaction—Epirubicin—uterine cancer	0.000306	0.0022	CcSEcCtD
Chlorpromazine—CYP2D6—female gonad—uterine cancer	0.000306	0.00232	CbGeAlD
Chlorpromazine—Dyspnoea—Etoposide—uterine cancer	0.000303	0.00218	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Epirubicin—uterine cancer	0.000303	0.00218	CcSEcCtD
Chlorpromazine—Somnolence—Etoposide—uterine cancer	0.000303	0.00218	CcSEcCtD
Chlorpromazine—ABCB1—renal system—uterine cancer	0.000302	0.00229	CbGeAlD
Chlorpromazine—Drowsiness—Epirubicin—uterine cancer	0.000299	0.00215	CcSEcCtD
Chlorpromazine—BCHE—lymph node—uterine cancer	0.000297	0.00225	CbGeAlD
Chlorpromazine—Pancytopenia—Doxorubicin—uterine cancer	0.000295	0.00212	CcSEcCtD
Chlorpromazine—ABCB1—endometrium—uterine cancer	0.000292	0.00221	CbGeAlD
Chlorpromazine—Jaundice—Epirubicin—uterine cancer	0.000292	0.0021	CcSEcCtD
Chlorpromazine—Constipation—Etoposide—uterine cancer	0.000291	0.0021	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000283	0.00204	CcSEcCtD
Chlorpromazine—ABCB1—mammalian vulva—uterine cancer	0.000282	0.00214	CbGeAlD
Chlorpromazine—Hyperglycaemia—Doxorubicin—uterine cancer	0.00028	0.00202	CcSEcCtD
Chlorpromazine—Agranulocytosis—Epirubicin—uterine cancer	0.000279	0.00201	CcSEcCtD
Chlorpromazine—Drowsiness—Doxorubicin—uterine cancer	0.000277	0.00199	CcSEcCtD
Chlorpromazine—Jaundice—Doxorubicin—uterine cancer	0.00027	0.00194	CcSEcCtD
Chlorpromazine—Body temperature increased—Etoposide—uterine cancer	0.000269	0.00194	CcSEcCtD
Chlorpromazine—ABCB1—uterus—uterine cancer	0.000269	0.00204	CbGeAlD
Chlorpromazine—Oedema peripheral—Epirubicin—uterine cancer	0.000265	0.0019	CcSEcCtD
Chlorpromazine—Visual impairment—Epirubicin—uterine cancer	0.000259	0.00186	CcSEcCtD
Chlorpromazine—Agranulocytosis—Doxorubicin—uterine cancer	0.000258	0.00186	CcSEcCtD
Chlorpromazine—HRH1—lymph node—uterine cancer	0.000258	0.00196	CbGeAlD
Chlorpromazine—ADRA2A—lymph node—uterine cancer	0.000254	0.00193	CbGeAlD
Chlorpromazine—Hypersensitivity—Etoposide—uterine cancer	0.000251	0.00181	CcSEcCtD
Chlorpromazine—Oedema peripheral—Doxorubicin—uterine cancer	0.000245	0.00176	CcSEcCtD
Chlorpromazine—ABCB1—female reproductive system—uterine cancer	0.000242	0.00183	CbGeAlD
Chlorpromazine—Visual impairment—Doxorubicin—uterine cancer	0.000239	0.00172	CcSEcCtD
Chlorpromazine—Nervousness—Epirubicin—uterine cancer	0.000227	0.00163	CcSEcCtD
Chlorpromazine—Dizziness—Etoposide—uterine cancer	0.000225	0.00162	CcSEcCtD
Chlorpromazine—Muscle spasms—Epirubicin—uterine cancer	0.000225	0.00162	CcSEcCtD
Chlorpromazine—ABCB1—female gonad—uterine cancer	0.00022	0.00167	CbGeAlD
Chlorpromazine—ABCB1—vagina—uterine cancer	0.000219	0.00166	CbGeAlD
Chlorpromazine—Nervousness—Doxorubicin—uterine cancer	0.00021	0.00151	CcSEcCtD
Chlorpromazine—Syncope—Epirubicin—uterine cancer	0.00021	0.00151	CcSEcCtD
Chlorpromazine—Leukopenia—Epirubicin—uterine cancer	0.000209	0.00151	CcSEcCtD
Chlorpromazine—Muscle spasms—Doxorubicin—uterine cancer	0.000208	0.0015	CcSEcCtD
Chlorpromazine—Loss of consciousness—Epirubicin—uterine cancer	0.000205	0.00148	CcSEcCtD
Chlorpromazine—Cough—Epirubicin—uterine cancer	0.000204	0.00147	CcSEcCtD
Chlorpromazine—Convulsion—Epirubicin—uterine cancer	0.000203	0.00146	CcSEcCtD
Chlorpromazine—Dry mouth—Epirubicin—uterine cancer	0.000195	0.0014	CcSEcCtD
Chlorpromazine—Syncope—Doxorubicin—uterine cancer	0.000194	0.0014	CcSEcCtD
Chlorpromazine—Leukopenia—Doxorubicin—uterine cancer	0.000194	0.00139	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Epirubicin—uterine cancer	0.000191	0.00137	CcSEcCtD
Chlorpromazine—Loss of consciousness—Doxorubicin—uterine cancer	0.00019	0.00137	CcSEcCtD
Chlorpromazine—Infection—Epirubicin—uterine cancer	0.00019	0.00136	CcSEcCtD
Chlorpromazine—Cough—Doxorubicin—uterine cancer	0.000189	0.00136	CcSEcCtD
Chlorpromazine—Shock—Epirubicin—uterine cancer	0.000188	0.00135	CcSEcCtD
Chlorpromazine—Convulsion—Doxorubicin—uterine cancer	0.000187	0.00135	CcSEcCtD
Chlorpromazine—Tachycardia—Epirubicin—uterine cancer	0.000186	0.00134	CcSEcCtD
Chlorpromazine—Dry mouth—Doxorubicin—uterine cancer	0.00018	0.0013	CcSEcCtD
Chlorpromazine—Hypotension—Epirubicin—uterine cancer	0.000178	0.00128	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000177	0.00127	CcSEcCtD
Chlorpromazine—Infection—Doxorubicin—uterine cancer	0.000175	0.00126	CcSEcCtD
Chlorpromazine—Shock—Doxorubicin—uterine cancer	0.000174	0.00125	CcSEcCtD
Chlorpromazine—Insomnia—Epirubicin—uterine cancer	0.000173	0.00124	CcSEcCtD
Chlorpromazine—Tachycardia—Doxorubicin—uterine cancer	0.000172	0.00124	CcSEcCtD
Chlorpromazine—Dyspnoea—Epirubicin—uterine cancer	0.00017	0.00122	CcSEcCtD
Chlorpromazine—Somnolence—Epirubicin—uterine cancer	0.00017	0.00122	CcSEcCtD
Chlorpromazine—Hypotension—Doxorubicin—uterine cancer	0.000165	0.00119	CcSEcCtD
Chlorpromazine—Constipation—Epirubicin—uterine cancer	0.000163	0.00117	CcSEcCtD
Chlorpromazine—Insomnia—Doxorubicin—uterine cancer	0.00016	0.00115	CcSEcCtD
Chlorpromazine—Dyspnoea—Doxorubicin—uterine cancer	0.000157	0.00113	CcSEcCtD
Chlorpromazine—Somnolence—Doxorubicin—uterine cancer	0.000157	0.00113	CcSEcCtD
Chlorpromazine—Constipation—Doxorubicin—uterine cancer	0.000151	0.00109	CcSEcCtD
Chlorpromazine—Body temperature increased—Epirubicin—uterine cancer	0.000151	0.00109	CcSEcCtD
Chlorpromazine—ABCB1—lymph node—uterine cancer	0.000141	0.00107	CbGeAlD
Chlorpromazine—Hypersensitivity—Epirubicin—uterine cancer	0.000141	0.00101	CcSEcCtD
Chlorpromazine—Body temperature increased—Doxorubicin—uterine cancer	0.00014	0.001	CcSEcCtD
Chlorpromazine—Hypersensitivity—Doxorubicin—uterine cancer	0.00013	0.000936	CcSEcCtD
Chlorpromazine—Dizziness—Epirubicin—uterine cancer	0.000126	0.000908	CcSEcCtD
Chlorpromazine—Dizziness—Doxorubicin—uterine cancer	0.000117	0.000841	CcSEcCtD
Chlorpromazine—DRD1—Signaling Pathways—KRAS—uterine cancer	5.71e-06	4.37e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—NRAS—uterine cancer	5.71e-06	4.36e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—NRAS—uterine cancer	5.68e-06	4.34e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—CTNNB1—uterine cancer	5.67e-06	4.33e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—CTNNB1—uterine cancer	5.66e-06	4.32e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—NRAS—uterine cancer	5.66e-06	4.32e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—NRAS—uterine cancer	5.66e-06	4.32e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—HRAS—uterine cancer	5.64e-06	4.31e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—CTNNB1—uterine cancer	5.64e-06	4.31e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—TP53—uterine cancer	5.64e-06	4.31e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—KRAS—uterine cancer	5.64e-06	4.31e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—HRAS—uterine cancer	5.64e-06	4.31e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—CTNNB1—uterine cancer	5.62e-06	4.3e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—PTEN—uterine cancer	5.62e-06	4.29e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CXCL8—uterine cancer	5.59e-06	4.27e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—CTNNB1—uterine cancer	5.57e-06	4.26e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—PIK3CA—uterine cancer	5.57e-06	4.25e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—HRAS—uterine cancer	5.56e-06	4.25e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—CTNNB1—uterine cancer	5.55e-06	4.24e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—PTEN—uterine cancer	5.53e-06	4.22e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—PTEN—uterine cancer	5.52e-06	4.22e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—PTEN—uterine cancer	5.52e-06	4.22e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—VEGFA—uterine cancer	5.5e-06	4.21e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—PTEN—uterine cancer	5.5e-06	4.2e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—PTEN—uterine cancer	5.49e-06	4.19e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling by GPCR—AKT1—uterine cancer	5.48e-06	4.19e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—PTEN—uterine cancer	5.48e-06	4.19e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—PIK3CA—uterine cancer	5.48e-06	4.19e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CDKN1B—uterine cancer	5.46e-06	4.17e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—KRAS—uterine cancer	5.45e-06	4.16e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—NRAS—uterine cancer	5.44e-06	4.15e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—PTEN—uterine cancer	5.43e-06	4.15e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—PTEN—uterine cancer	5.41e-06	4.14e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—GPCR downstream signaling—AKT1—uterine cancer	5.4e-06	4.13e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—HRAS—uterine cancer	5.4e-06	4.12e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling by GPCR—AKT1—uterine cancer	5.39e-06	4.12e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—TP53—uterine cancer	5.39e-06	4.12e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling by GPCR—AKT1—uterine cancer	5.38e-06	4.11e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—ERBB2—uterine cancer	5.38e-06	4.11e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling by GPCR—AKT1—uterine cancer	5.36e-06	4.1e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—EP300—uterine cancer	5.36e-06	4.09e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling by GPCR—AKT1—uterine cancer	5.35e-06	4.09e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—PTEN—uterine cancer	5.31e-06	4.06e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—PTEN—uterine cancer	5.31e-06	4.06e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—PIK3CA—uterine cancer	5.3e-06	4.05e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—PIK3CA—uterine cancer	5.3e-06	4.05e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling by GPCR—AKT1—uterine cancer	5.3e-06	4.05e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling by GPCR—AKT1—uterine cancer	5.28e-06	4.04e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—KRAS—uterine cancer	5.27e-06	4.03e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—KRAS—uterine cancer	5.27e-06	4.03e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—EP300—uterine cancer	5.27e-06	4.03e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—EP300—uterine cancer	5.27e-06	4.03e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—EP300—uterine cancer	5.26e-06	4.02e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.26e-06	4.02e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—PIK3CA—uterine cancer	5.25e-06	4.01e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—EP300—uterine cancer	5.24e-06	4.01e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—EP300—uterine cancer	5.23e-06	4e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—EP300—uterine cancer	5.23e-06	3.99e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—ERBB2—uterine cancer	5.21e-06	3.98e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—ERBB2—uterine cancer	5.21e-06	3.98e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—PIK3CA—uterine cancer	5.18e-06	3.96e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—EP300—uterine cancer	5.18e-06	3.96e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—EP300—uterine cancer	5.16e-06	3.94e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CTNNB1—uterine cancer	5.16e-06	3.94e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—HRAS—uterine cancer	5.15e-06	3.94e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CXCL8—uterine cancer	5.1e-06	3.9e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—TP53—uterine cancer	5.08e-06	3.88e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—VEGFA—uterine cancer	5.08e-06	3.88e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—HRAS—uterine cancer	5.07e-06	3.87e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—EP300—uterine cancer	5.06e-06	3.87e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—EP300—uterine cancer	5.06e-06	3.87e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—KRAS—uterine cancer	5.03e-06	3.85e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—PTEN—uterine cancer	5.03e-06	3.84e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—NRAS—uterine cancer	5.01e-06	3.83e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—TP53—uterine cancer	5.01e-06	3.83e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—PIK3CA—uterine cancer	5.01e-06	3.83e-05	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—PIK3CA—uterine cancer	5.01e-06	3.83e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—VEGFA—uterine cancer	4.99e-06	3.82e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CDKN1B—uterine cancer	4.98e-06	3.81e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—VEGFA—uterine cancer	4.98e-06	3.81e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—AKT1—uterine cancer	4.98e-06	3.81e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—AKT1—uterine cancer	4.98e-06	3.8e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—VEGFA—uterine cancer	4.97e-06	3.8e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—VEGFA—uterine cancer	4.95e-06	3.78e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CXCL8—uterine cancer	4.94e-06	3.77e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CXCL8—uterine cancer	4.94e-06	3.77e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—NRAS—uterine cancer	4.93e-06	3.77e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—NRAS—uterine cancer	4.92e-06	3.76e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—KRAS—uterine cancer	4.91e-06	3.75e-05	CbGpPWpGaD
Chlorpromazine—BCHE—Metabolism—AKT1—uterine cancer	4.91e-06	3.75e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—AKT1—uterine cancer	4.91e-06	3.75e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—NRAS—uterine cancer	4.91e-06	3.75e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—HRAS—uterine cancer	4.91e-06	3.75e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—HRAS—uterine cancer	4.91e-06	3.75e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—VEGFA—uterine cancer	4.9e-06	3.75e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—NRAS—uterine cancer	4.89e-06	3.74e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—VEGFA—uterine cancer	4.89e-06	3.74e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—KRAS—uterine cancer	4.89e-06	3.74e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—KRAS—uterine cancer	4.87e-06	3.72e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—KRAS—uterine cancer	4.87e-06	3.72e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—HRAS—uterine cancer	4.86e-06	3.71e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—PIK3CA—uterine cancer	4.84e-06	3.7e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—PIK3CA—uterine cancer	4.84e-06	3.7e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—NRAS—uterine cancer	4.84e-06	3.7e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—NRAS—uterine cancer	4.83e-06	3.69e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CDKN1B—uterine cancer	4.82e-06	3.68e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CDKN1B—uterine cancer	4.82e-06	3.68e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—EP300—uterine cancer	4.8e-06	3.67e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—HRAS—uterine cancer	4.79e-06	3.66e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—AKT1—uterine cancer	4.76e-06	3.64e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PTEN—uterine cancer	4.75e-06	3.63e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CTNNB1—uterine cancer	4.71e-06	3.6e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—KRAS—uterine cancer	4.68e-06	3.58e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—HRAS—uterine cancer	4.63e-06	3.54e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—PIK3CA—uterine cancer	4.62e-06	3.53e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—PIK3CA—uterine cancer	4.62e-06	3.53e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—MTHFR—uterine cancer	4.61e-06	3.52e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—PTEN—uterine cancer	4.59e-06	3.51e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CTNNB1—uterine cancer	4.56e-06	3.48e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CTNNB1—uterine cancer	4.56e-06	3.48e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—AKT1—uterine cancer	4.55e-06	3.48e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—VEGFA—uterine cancer	4.54e-06	3.47e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—EP300—uterine cancer	4.53e-06	3.46e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—PIK3CA—uterine cancer	4.51e-06	3.45e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—PIK3CA—uterine cancer	4.49e-06	3.43e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—NRAS—uterine cancer	4.49e-06	3.43e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—HRAS—uterine cancer	4.48e-06	3.42e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—HRAS—uterine cancer	4.48e-06	3.42e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—AKT1—uterine cancer	4.48e-06	3.42e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—PIK3CA—uterine cancer	4.47e-06	3.42e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—PIK3CA—uterine cancer	4.47e-06	3.42e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—PTEN—uterine cancer	4.44e-06	3.39e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—PTEN—uterine cancer	4.44e-06	3.39e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—EP300—uterine cancer	4.38e-06	3.34e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—TP53—uterine cancer	4.37e-06	3.34e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—TP53—uterine cancer	4.35e-06	3.32e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—AKT1—uterine cancer	4.33e-06	3.31e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—AKT1—uterine cancer	4.33e-06	3.31e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—KRAS—uterine cancer	4.31e-06	3.3e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—PIK3CA—uterine cancer	4.3e-06	3.29e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—AKT1—uterine cancer	4.29e-06	3.28e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—HRAS—uterine cancer	4.28e-06	3.27e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—KRAS—uterine cancer	4.25e-06	3.24e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—PIK3CA—uterine cancer	4.24e-06	3.24e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—KRAS—uterine cancer	4.24e-06	3.24e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—EP300—uterine cancer	4.23e-06	3.24e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—EP300—uterine cancer	4.23e-06	3.24e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—AKT1—uterine cancer	4.23e-06	3.23e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—KRAS—uterine cancer	4.22e-06	3.23e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—KRAS—uterine cancer	4.21e-06	3.22e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—HRAS—uterine cancer	4.18e-06	3.19e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—KRAS—uterine cancer	4.17e-06	3.18e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PTEN—uterine cancer	4.16e-06	3.18e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—TP53—uterine cancer	4.16e-06	3.18e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—KRAS—uterine cancer	4.16e-06	3.18e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—HRAS—uterine cancer	4.16e-06	3.18e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—VEGFA—uterine cancer	4.15e-06	3.17e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—HRAS—uterine cancer	4.14e-06	3.16e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—HRAS—uterine cancer	4.14e-06	3.16e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—NRAS—uterine cancer	4.09e-06	3.13e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—AKT1—uterine cancer	4.09e-06	3.13e-05	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—AKT1—uterine cancer	4.09e-06	3.13e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—VEGFA—uterine cancer	4.01e-06	3.06e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—VEGFA—uterine cancer	4.01e-06	3.06e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—HRAS—uterine cancer	3.98e-06	3.04e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—EP300—uterine cancer	3.97e-06	3.03e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—PIK3CA—uterine cancer	3.96e-06	3.03e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—NRAS—uterine cancer	3.96e-06	3.03e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—NRAS—uterine cancer	3.96e-06	3.03e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—AKT1—uterine cancer	3.96e-06	3.02e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—AKT1—uterine cancer	3.96e-06	3.02e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PTEN—uterine cancer	3.92e-06	3e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—PIK3CA—uterine cancer	3.9e-06	2.98e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—PIK3CA—uterine cancer	3.9e-06	2.98e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—PIK3CA—uterine cancer	3.89e-06	2.97e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—PIK3CA—uterine cancer	3.88e-06	2.96e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—PIK3CA—uterine cancer	3.87e-06	2.96e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—PIK3CA—uterine cancer	3.87e-06	2.95e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—KRAS—uterine cancer	3.86e-06	2.95e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—TP53—uterine cancer	3.83e-06	2.93e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—PIK3CA—uterine cancer	3.83e-06	2.93e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—PIK3CA—uterine cancer	3.82e-06	2.92e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—AKT1—uterine cancer	3.78e-06	2.89e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—AKT1—uterine cancer	3.78e-06	2.89e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—TP53—uterine cancer	3.77e-06	2.88e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—TP53—uterine cancer	3.77e-06	2.88e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—TP53—uterine cancer	3.75e-06	2.87e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—PIK3CA—uterine cancer	3.75e-06	2.86e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—PIK3CA—uterine cancer	3.75e-06	2.86e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—TP53—uterine cancer	3.74e-06	2.86e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—EP300—uterine cancer	3.74e-06	2.86e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—TP53—uterine cancer	3.7e-06	2.83e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—TP53—uterine cancer	3.69e-06	2.82e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—AKT1—uterine cancer	3.69e-06	2.82e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—AKT1—uterine cancer	3.67e-06	2.8e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—HRAS—uterine cancer	3.67e-06	2.8e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—AKT1—uterine cancer	3.65e-06	2.79e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—AKT1—uterine cancer	3.65e-06	2.79e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—HRAS—uterine cancer	3.61e-06	2.76e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—HRAS—uterine cancer	3.6e-06	2.75e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—HRAS—uterine cancer	3.59e-06	2.74e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—HRAS—uterine cancer	3.58e-06	2.73e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—PIK3CA—uterine cancer	3.55e-06	2.71e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—HRAS—uterine cancer	3.54e-06	2.71e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—HRAS—uterine cancer	3.53e-06	2.7e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—KRAS—uterine cancer	3.52e-06	2.69e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—AKT1—uterine cancer	3.51e-06	2.68e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—AKT1—uterine cancer	3.47e-06	2.65e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—TP53—uterine cancer	3.43e-06	2.62e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—KRAS—uterine cancer	3.41e-06	2.6e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—KRAS—uterine cancer	3.41e-06	2.6e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PIK3CA—uterine cancer	3.35e-06	2.56e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PTEN—uterine cancer	3.32e-06	2.54e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—HRAS—uterine cancer	3.28e-06	2.51e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—AKT1—uterine cancer	3.24e-06	2.47e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—PIK3CA—uterine cancer	3.24e-06	2.47e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—AKT1—uterine cancer	3.19e-06	2.43e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—AKT1—uterine cancer	3.18e-06	2.43e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—AKT1—uterine cancer	3.18e-06	2.43e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—AKT1—uterine cancer	3.17e-06	2.42e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—EP300—uterine cancer	3.17e-06	2.42e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—AKT1—uterine cancer	3.16e-06	2.42e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—AKT1—uterine cancer	3.16e-06	2.41e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—TP53—uterine cancer	3.13e-06	2.39e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—PIK3CA—uterine cancer	3.13e-06	2.39e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—PIK3CA—uterine cancer	3.13e-06	2.39e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—AKT1—uterine cancer	3.13e-06	2.39e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—AKT1—uterine cancer	3.12e-06	2.38e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—AKT1—uterine cancer	3.06e-06	2.34e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—AKT1—uterine cancer	3.06e-06	2.34e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—TP53—uterine cancer	3.03e-06	2.32e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—TP53—uterine cancer	3.03e-06	2.32e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—HRAS—uterine cancer	3e-06	2.29e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PIK3CA—uterine cancer	2.93e-06	2.24e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—AKT1—uterine cancer	2.9e-06	2.21e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—HRAS—uterine cancer	2.9e-06	2.21e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—HRAS—uterine cancer	2.9e-06	2.21e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.77e-06	2.11e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—AKT1—uterine cancer	2.74e-06	2.09e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—AKT1—uterine cancer	2.64e-06	2.02e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PTEN—uterine cancer	2.56e-06	1.96e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—AKT1—uterine cancer	2.56e-06	1.95e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—AKT1—uterine cancer	2.56e-06	1.95e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—EP300—uterine cancer	2.44e-06	1.87e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—AKT1—uterine cancer	2.4e-06	1.83e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PIK3CA—uterine cancer	2.34e-06	1.79e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—AKT1—uterine cancer	2.26e-06	1.73e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—AKT1—uterine cancer	1.91e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.81e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—AKT1—uterine cancer	1.48e-06	1.13e-05	CbGpPWpGaD
